- Home
- PMEC vs RLYB Comparison
PMEC vs RLYB Comparison
Compare PMEC & RLYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PMEC | RLYB |
|---|---|---|
| Founded | 1984 | 2018 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.5M | 28.7M |
| IPO Year | 2021 | 2021 |
Fundamental Metrics
Financial Performance| Metric | PMEC | RLYB |
|---|---|---|
| Price | $0.70 | $8.13 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 63.6K | ★ 250.4K |
| Earning Date | 07-24-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $858,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 43.00 |
| 52 Week Low | $0.60 | $0.22 |
| 52 Week High | $2.44 | $11.49 |
Technical Indicators
Market Signals| Indicator | PMEC | RLYB |
|---|---|---|
| Relative Strength Index (RSI) | 45.76 | 50.51 |
| Support Level | $0.60 | $0.48 |
| Resistance Level | $0.79 | $11.49 |
| Average True Range (ATR) | 0.05 | 0.68 |
| MACD | 0.01 | -0.45 |
| Stochastic Oscillator | 39.55 | 2.97 |
Price Performance
Historical ComparisonAbout PMEC Primech Holdings Ltd.
Primech Holdings Ltd is a technology-driven facilities services provider in the public and private sectors operating mainly in Singapore. The services offered by the company include Facilities services, Stewarding services, Cleaning services to offices, Cleaning services to homes, and Cleaning Supplies.
About RLYB Rallybio Corporation
Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. The programs of the company are for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.